MYCOSPOR

This brand name is authorized in Japan, Mexico, Turkey

Active ingredients

The drug MYCOSPOR contains one active pharmaceutical ingredient (API):

1 Bifonazole
UNII QYJ305Z91O - BIFONAZOLE

Bifonazole is an imidazole derivative with a broad antimycotic spectrum, which includes dermatophytes, yeasts, moulds and other fungi such as Malassezia furfur. It is also effective against Corynebacterium minutissimum.

Read about Bifonazole

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
D01AC10 Bifonazole D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AC Imidazole and triazole derivatives
Discover more medicines within D01AC10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: JP 医薬品医療機器総合機構 Identifier(s): 2655708N1261, 2655708Q1179
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 402M90, 448M90, 496M89
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699546351411

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.